Eliminación de la transmisión vertical del VIH mediante terapia antirretroviral: ¿Es posible prevenir todos los casos?

Contenido principal del artículo

MD Ivan Enrique Prins-Diaz
MD Dayana Paola Mora-Sánchez
MD Yudex Abraham Vergara-Jacome
MD Yelson Alejandro Picón-Jaimes

Keywords

Abstract 48 | PDF Downloads 27

Citas

1. World Health Organization. Global HIV Programme: Mother-to-child transmission of HIV [Internet]. [consultado 2023 Dic 18]. Disponible en: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/prevention/mother-to-child-transmission-of-hiv

2. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030 [Internet]. [consultado 2023 Dic 18]. Disponible en: https://www.who.int/publications/i/item/9789240053779

3. Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, et al. Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery. Clin Infect Dis. 2023;76(3). Doi: 10.1093/cid/ciac703 PMID: 36037040.

4. Uthman OA, Nachega JB, Anderson J, Kanters S, Mills EJ, Renaud F, et al. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis. Lancet HIV. 2017;4(1). Doi: 10.1016/S2352-3018(16)30195-3

5. Horner MJ, Hazra R, Barnholtz-Sloan JS, Shiels MS, Engels EA. Cancer risk among HIV-exposed uninfected children in the United States. AIDS. 2023; 37(3):549-551. Doi: 10.1097/QAD.0000000000003458.

Artículos más leídos del mismo autor/a